Archive for August, 2018

BVI holding Juvenescence Ltd founded Napa Therapeutics in cooperation with Buck Institute and Insilico Medicine

Thursday, August 16th, 2018

BVI-registered Juvenescence Ltd, which is focused on ageing research and therapy investments, together with the Buck Institute for Research on Aging and Insilico Medicine have formed Napa Therapeutics, Ltd. – a biotechnology company focused on a novel target linked to one of the fundamental processes of ageing, and developing molecule drugs to address this target.

Napa Therapeutics is based on an innovative research in NAD metabolism conducted in the laboratory of Eric Verdin, President and CEO of the Buck Institute – and independent non-profit institution which is one of the main research centres focused on the problems of ageing and age-related diseases. Napa is a privately held British Virgin Islands company having an office in the Isle of Man.

Insilico Medicine is an artificial intelligence company with offices and resources in the US, Belgium, Russia, the UK, Taiwan and Korea. The Verdin lab will collaborate with Napa Therapeutics and use Insilico’s drug development engine to speed the discovery of new compounds.